Comparison Between Low Carbohydrate Diet and Traditionally Recommended Diabetic Diet in the Treatment of Diabetes Mellitus Type 2.
NCT01005498 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2011-12-06
Summary
The purpose of the clinical trial is to investigate whether low carbohydrate diet is better than the traditional diabetic diet in the treatment of patients with diabetes mellitus type 2, for blood sugar and body weight.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Low carbohydrate - high fat diet
The diet has an energy content of 1600 kcal or 1800, with 50% from fat, 20% from carbohydrates and 30% from proteins.
- DIETARY_SUPPLEMENT
-
High carbohydrate - low fat diet
The diet has an energy content of 1600 or 1800 kcal, with 30% from fat, 55-60% from carbohydrates and 10-15% from proteins.
Sponsors & Collaborators
-
Vårdcentralen Lyckorna
lead OTHER
Principal Investigators
-
Hans G Guldbrand · Vårdcentralen Lyckorna
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2011-03-31
- Completion
- 2011-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet
NCT03710928 ·Status: RECRUITING ·Phase: NA
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2
-
Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
NCT02113332 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
NCT00993304 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
NCT01686945 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of New Dietary Treatment of Diabetes
NCT00128089 ·Status: TERMINATED ·Phase: PHASE1
-
Diabetes Intervention Accentuating Diet and Enhancing Metabolism
NCT03225339 ·Status: COMPLETED ·Phase: NA
-
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
NCT05499702 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
NCT01509742 ·Status: COMPLETED ·Phase: PHASE1
-
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135 ·Status: COMPLETED ·Phase: NA
-
Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease
NCT04057261 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes
NCT04416204 ·Status: COMPLETED ·Phase: NA
-
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
NCT02403284 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
NCT02443155 ·Status: COMPLETED ·Phase: PHASE2
-
52 Week Trial of Liraglutide in Type 1 Diabetes
NCT01787916 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure.
NCT01071772 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
NCT03555994 ·Status: COMPLETED ·Phase: PHASE2
-
Duodenal Exclusion for the Treatment of Type 2 Diabetes
NCT00534547 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
NCT04472962 ·Status: COMPLETED ·Phase: NA
-
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes
NCT01595789 ·Status: COMPLETED ·Phase: PHASE4
-
Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT01663220 ·Status: COMPLETED
-
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
NCT03590626 ·Status: COMPLETED ·Phase: NA
-
The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
NCT01472640 ·Status: COMPLETED ·Phase: NA